Transition Metal(II)–Salen and –Salophen Macrocyclic Complexes
4 H, e), 3.29 (s, 4 H, k), 1.22 (s, 18 H, E) ppm. 13C NMR PdII·Na (752 mg, 80%) as a orange solid. 1H NMR (400 MHz, [D6]-
(150 MHz, CD3CN, 25 °C): δ = 163.2, 152.7, 150.6, 147.9, 147.6,
130.2, 128.3, 124.8, 124.7, 120.5, 120.2, 114.8, 114.1, 111.9, 68.8,
DMSO, 25 °C): δ = 9.37 (s, 2 H, jЈ), 9.22 (s, 2 H, j), 8.74 (s, 2 H,
m), 8.45 (d, J = 9 Hz, 2 H, k), 8.02 (d, J = 9 Hz, 2 H, l), 7.43 (m,
4 H, i), 7.08 (br., 4 H, g), 6.98 (m, 4 H, b), 6.91 (m, 4 H, a), 6.66
(m, 4 H, h), 4.21 (br., 8 H, f), 4.14 (br., 8 H, c), 3.97 (br., 8 H, e),
68.3, 67.6, 67.1, 58.4, 50.4, 33.9, 30.3 ppm. IR (KBr): ν = 3436,
˜
3094, 2958, 1629, 1607, 1549, 1504, 1450, 1304, 1228, 1132, 1089,
839 (PF6 ), 741, 557 cm–1. MS (FAB): m/z (%) = 916 (72) [M – 3.89 (br., 8 H, d) ppm. IR (KBr): ν = 3003, 2391, 1853, 1630, 1481,
–
˜
PF6]+. C52H64F6N3NiO8P (1062.75): calcd. C 58.77, H 6.07, N
3.95; found C 59.07, H 6.27, N 3.61. Selected data for 3b-H·PF6:
M.p. 314–315 °C. 1H NMR (600 MHz, CD3CN, 25 °C): δ = 8.73
(br., 2 H, D), 8.44 (s, 2 H, j), 7.73 (m, 2 H, k), 7.28 (d, J = 8.4 Hz,
4 H, C), 7.24 (d, J = 8.4 Hz, 4 H, B), 7.21 (m, 2 H, l), 7.19 (d, J =
7.8 Hz, 2 H, i), 6.94 (m, 2 H, b), 6.89 (m, 2 H, a), 6.73 (d, J =
7.8 Hz, 2 H, g), 6.64 (t, J = 7.8 Hz, 2 H, h), 4.78 (t, J = 6.6 Hz, 4
H, A), 4.28 (m, 4 H, c), 3.88 (m, 4 H, d), 3.72 (s, 8 H, e/f), 1.09 (s,
18 H, E) ppm. 13C NMR (150 MHz, CD3CN, 25 °C): δ = 156.9,
154.2, 150.9, 147.8, 147.5, 142.0, 130.1, 128.2, 127.9, 126.6, 124.6,
120.5, 120.3, 115.6, 115.5, 115.1, 111.9, 68.8, 68.0, 67.6, 67.0, 50.6,
1346, 1163, 1053 (ClO4 ), 976 cm–1. MS (MALDI-TOF): m/z (%)
–
= 1428 (100) [M + 1 – Na – 2ClO4]+, 1548 (4) [M – 1 – ClO4]+.
5-H·ClO4 and 6-2H·2ClO4: A solution of 2-H·PF6 (592 mg,
1.3 mmol) in MeCN (20 mL) was added to a solution of the bis-
macrocycle with potassium(I) perchlorate 4-K (173 mg, 0.13 mmol)
in CH2Cl2 (20 mL) and stirred for 16 h at r.t. Then, solid Pd-
(OAc)2 (87 mg, 0.39 mmol) was added, and the reaction mixture
was stirred for 4 h. The solvent was evaporated under reduced pres-
sure, and the residue was dissolved in CH2Cl2 and filtered through
a column (SiO2; CH2Cl2/MeOH, 98:2). The crude material was
purified by GPC (CHCl3) to afford 6-2H·2ClO4 as a red-orange
33.7, 30.0 ppm. IR (KBr): ν = 3067, 2961, 1618, 1441, 1258, 1204,
˜
solid (58 mg, 20%). Selected data for 5-H·ClO : IR (KBr): ν = 1100
˜
4
–
1103, 840 (PF6 ), 743, 556 cm–1. MS (FAB): m/z (%) = 965 (90) [M
–
(ClO4 ) cm–1. MS (FAB): m/z (%) = 1715 (18) [M – ClO4]+. Selected
+ 1 – PF6]+. C56H64F6N3NiO8P (1110.79): calcd. C 60.55, H 5.81,
1
data for 6-2H·2ClO4: M.p. 184–187 °C. H NMR (400 MHz, [D6]-
N 3.78; found C 60.88, H 5.88, N 3.47.
DMSO, 25 °C): δ = 9.22 (s, 2 H, jЈ), 9.06 (m, 4 H, D), 8.68 (s, 2 H,
j), 8.33 (m, 2 H, m), 8.32 (s, 2 H, k), 8.03 (m, 2 H, l), 7.36 (m, 4
H, i), 7.25 (m, 8 H, C), 7.11 (m, 8 H, B), 6.95 (m, 4 H, b), 6.83 (m,
8 H, g, a), 6.75 (t, J = 8 Hz, 2 H, h), 6.47 (br., 2 H, hЈ), 4.79 (br.,
8 H, A), 4.22 (m, 8 H, c), 4.12 (m, 4 H, e), 4.02 (m, 4 H, eЈ), 3.91
4-Ba: A solution of the dialdehyde-functionalized crown ether
derivative (526.5 mg, 1.0 mmol) and 3,3Ј-diaminobenzidine
(107.2 mg, 0.5 mmol) in dry THF (20 mL) was added over 2 h to a
solution of barium perchlorate (336.3 mg, 1.0 mmol) heated under
reflux in dry MeOH (100 mL). The mixture was heated under re-
flux for an additional 24 h. During the reaction, an orange-colored
solid precipitated out. This solid was filtered off and washed with
CH2Cl2 to afford the barium perchlorate–bismacrocycle complex
4-Ba as an orange solid (691 mg, 74%). M.p. 221–226 °C. 1H NMR
(400 MHz, CD3CN, 25 °C): δ = 14.89–14.67 (m, 4 H, OH), 9.42
(br., 2 H, jЈ), 9.04 (br., 2 H, j), 8.02 (s, 2 H, m), 7.95–7.90 (m, 2 H,
k), 7.74–7.69 (m, 2 H, l), 7.24 (m, 4 H, i), 7.08 (m, 4 H, g), 6.93–
(br., 8 H, d), 3.81 (br., 8 H, f) ppm. IR (KBr): ν = 3181, 2060,
˜
–
1856, 1525, 1488, 1382, 1090 (ClO4 ), 989, 687 cm–1. MS (FAB):
m/z (%) = 2023 (6) [M – 1 – ClO4]+, 1012 (13) [M – 2 ClO4]2+
.
8-H·Rh(TPP)Cl·ClO4: The thread-like salt 7-H·O2CCF3 (44 mg,
0.12 mmol) was added to a CH2Cl2/MeCN (10:1, 50 mL) solution
of the salophen macrocycle with palladium(II)-sodium(I) 1b-
PdII·Na(I) (100 mg, 0.12 mmol) and stirred for 1 h at r.t. Then,
solid Rh(TPP)Cl (90 mg, 0.12 mmol) was added, and the reaction
mixture was stirred for 60 h. The solvent was evaporated under
reduced pressure. The residue was dissolved in CH2Cl2 and chro-
matographed (SiO2; CH2Cl2/MeOH, 98:2) to afford the 8-
H·Rh(TPP)Cl·ClO4 as a violet solid (86 mg, 40%). 1H NMR
(400 MHz, CDCl3, 25 °C): δ = 8.79 (s, 10 H, j, 6), 8.35 (br., 2 H,
H), 8.24 (m, 4 H, 5), 8.04 (m, 2 H, F), 7.83 (d, J = 7 Hz, 4 H, 4),
7.70 (m, 8 H, 1, 3), 7.52 (m, 4 H, 2), 7.33 (m, 2 H, k), 7.11 (br., 2
H, E), 6.85 (m, 2 H, b), 6.70 (d, J = 8 Hz, 2 H, g), 6.65 (m, 2 H,
a), 6.53 (d, J = 8 Hz, 2 H, l), 6.33 (m, 2 H, i), 6.17 (m, 2 H, h),
5.44 (m, 2 H, B), 4.13 (m, 4 H, c), 4.01 (m, 8 H, f, e), 3.95 (m, 4
H, d), 3.84 (m, 2 H, C), 3.75 (br., 2 H, D), 1.05 (d, J = 7 Hz, 2 H,
A), 0.88 (s, 9 H, G) ppm. MS (MALDI-TOF): m/z (%) = 835 (4)
6.85 (m, 8 H, a, b), 6.61 (m, 4 H, h), 4.47 (m, 8 H, f), 3.97–3.82
–
(m, 24 H, c–e) ppm. IR (KBr): ν = 1080 (ClO ) cm–1. MS (FAB):
˜
4
m/z (%) = 1431 (10) [M – Ba – 3ClO4]+. C68H66Ba2Cl4N4O32·3H2O
(1921.80): calcd. C 42.50, H 3.78, N 2.92; found C 42.23, H 3.92,
N 2.69.
4-K and 4-Na: A solution of potassium sulfate (1 g, 5.7 mmol) or
sodium sulfate (0.81 g, 5.7 mmol) in H2O (50 mL) was added to a
solution of 4-Ba (1.06 g, 0.57 mmol) in a solution of MeOH/THF/
MeCN/Me2CO (4:4:1:1, 200 mL), and then the mixture was stirred
at r.t. for 3 h. The reaction mixture was filtered to remove the pre-
cipitated barium sulfate. The solvent was evaporated, and the resi-
due was dried under high vacuum to yield 4-K as an orange solid
(684 mg, 90%) or 4-Na as an orange solid (683 mg, 91%). Selected
[M – 1 – ClO4 – Cl]2+
.
1
data for 4-K: H NMR (400 MHz, [D6]DMSO, 25 °C): δ = 13.59–
X-ray Measurements: X-ray data were obtained with a Bruker
SMART-CCD diffractometer; structural determination and refine-
ment were performed by using SAINT[18] and SHELXTL[19] soft-
ware packages, and the empirical absorption correction was per-
formed by using the SADABS[20] program. All structures were
solved by direct methods and refined by a full-matrix least-squares
method.
13.56 (m, 4 H, OH), 9.11–9.02 (m, 4 H, j, jЈ), 8.55 (s, 2 H, m), 7.99
(m, 2 H, k), 7.67 (m, 2 H, l), 7.29–7.26 (m, 4 H, i), 7.15–7.14 (m,
4 H, g), 6.98–6.91 (m, 8 H, a, b), 6.89–6.86 (m, 4 H, h), 4.17 (m, 8
H, f), 4.11 (m, 8 H, c), 3.86 (m, 8 H, e), 3.83–3.82 (m, 8 H, d) ppm.
13C NMR (100 MHz, [D6]DMSO, 25 °C): δ = 192.3, 192.2, 150.9,
150.8, 150.3, 148.1, 147.7, 147.6, 146.8, 146.3, 146.0, 143.9, 124.2,
121.8, 121.7, 120.8, 120.6, 118.7, 118.6, 118.0, 114.3, 113.7, 98.7,
–
54.3, 52.6, 48.0, 30.0 ppm. IR (KBr): ν = 1100 (ClO ) cm–1. MS
˜
Crystallographic Data
4
(FAB): m/z (%) = 1233 (10) [M – ClO4]+.
3a-H·PF6:
[Ni(C30H32N2O8)C22H32N]2(PF6)2·CH2Cl2·C4H8O2,
4-PdII·Na: Solid palladium(II) acetate (384 mg, 1.71 mmol) was C109H138Cl2F12N6Ni2O18P2, M = 2298.51, monoclinic, space group
added to a CH2Cl2/THF/MeOH (6:2:2, 200 mL) solution of 4-Na C2/c, a = 67.469(4) Å, b = 13.7577(8) Å, c = 24.5387(14) Å, β =
(751 mg, 0.57 mmol), and then the mixture was stirred at r.t. for 96.183(2)°, V = 22645(2) Å3, Z = 8, ρcalcd. = 1.348 gcm–3, µ(Mo-
2 h. The solvent was evaporated under reduced pressure. The resi-
due was dissolved in a small amount of MeCN and purified by
column chromatography (SiO2; CH2Cl2/MeOH, 98:2) to afford 4-
Kα)
=
4.94 cm–1,
T
=
183(2) K, yellow-brown plates,
0.20ϫ0.15ϫ0.10 mm, R1 = 0.0819 [IϾ2σ(I)], wR2 = 0.2822 (all
data), GOF = 0.940.
Eur. J. Inorg. Chem. 2007, 4229–4237
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
4235